FI97479C - Menetelmä Plasmodium falciparum SGE2 -kannan HRPII-antigeenin ja tätä antigeeniä sisältävän malariarokotteen valmistamiseksi, HRPII-antigeeniä koodaava DNA- ja RNA-sekvenssi ja tätä DNA:ta sisältävä vektori ja bakteerisolu - Google Patents

Menetelmä Plasmodium falciparum SGE2 -kannan HRPII-antigeenin ja tätä antigeeniä sisältävän malariarokotteen valmistamiseksi, HRPII-antigeeniä koodaava DNA- ja RNA-sekvenssi ja tätä DNA:ta sisältävä vektori ja bakteerisolu

Info

Publication number
FI97479C
FI97479C FI885023A FI885023A FI97479C FI 97479 C FI97479 C FI 97479C FI 885023 A FI885023 A FI 885023A FI 885023 A FI885023 A FI 885023A FI 97479 C FI97479 C FI 97479C
Authority
FI
Finland
Prior art keywords
antigen
dna
hrpii
vector
plasmodium falciparum
Prior art date
Application number
FI885023A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI885023A0 (fi
FI885023L (fi
FI97479B (fi
Inventor
Bernhard Knapp
Erika Hundt
Burkhard Enders
Hans Kuepper
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of FI885023A0 publication Critical patent/FI885023A0/fi
Publication of FI885023L publication Critical patent/FI885023L/fi
Application granted granted Critical
Publication of FI97479B publication Critical patent/FI97479B/fi
Publication of FI97479C publication Critical patent/FI97479C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6893—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI885023A 1987-11-03 1988-11-01 Menetelmä Plasmodium falciparum SGE2 -kannan HRPII-antigeenin ja tätä antigeeniä sisältävän malariarokotteen valmistamiseksi, HRPII-antigeeniä koodaava DNA- ja RNA-sekvenssi ja tätä DNA:ta sisältävä vektori ja bakteerisolu FI97479C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19873737238 DE3737238A1 (de) 1987-11-03 1987-11-03 Rekombinantes histidinreiches protein (37 kd antigen) von plasmodium falciparum, seine herstellung und verwendung
DE3737238 1987-11-03

Publications (4)

Publication Number Publication Date
FI885023A0 FI885023A0 (fi) 1988-11-01
FI885023L FI885023L (fi) 1989-05-04
FI97479B FI97479B (fi) 1996-09-13
FI97479C true FI97479C (fi) 1996-12-27

Family

ID=6339664

Family Applications (1)

Application Number Title Priority Date Filing Date
FI885023A FI97479C (fi) 1987-11-03 1988-11-01 Menetelmä Plasmodium falciparum SGE2 -kannan HRPII-antigeenin ja tätä antigeeniä sisältävän malariarokotteen valmistamiseksi, HRPII-antigeeniä koodaava DNA- ja RNA-sekvenssi ja tätä DNA:ta sisältävä vektori ja bakteerisolu

Country Status (12)

Country Link
US (1) US5393523A (fr)
EP (1) EP0315085B1 (fr)
JP (1) JPH01165398A (fr)
KR (1) KR970009346B1 (fr)
AT (1) ATE83928T1 (fr)
AU (1) AU618030B2 (fr)
DE (2) DE3737238A1 (fr)
DK (1) DK610588A (fr)
ES (1) ES2037795T3 (fr)
FI (1) FI97479C (fr)
GR (1) GR3007476T3 (fr)
PT (1) PT88915B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0474891A1 (fr) * 1990-09-08 1992-03-18 BEHRINGWERKE Aktiengesellschaft Vecteurs pour l'expression d'antigènes malariales sur la surface de souches vaccinales de Salmonella
DE4041836A1 (de) * 1990-12-24 1992-06-25 Behringwerke Ag Protektive plasmodium falciparum hybridproteine, die teilsequenzen der malaria-antigene hrpii und serp enthalten, ihre herstellung und verwendung
AU670108B2 (en) * 1992-09-11 1996-07-04 Becton Dickinson & Company Improved antibodies to plasmodium falciparum
EP1754717A1 (fr) 2005-08-19 2007-02-21 Université de Lausanne Peptides antigéniques et leurs utilisations
WO2009097159A1 (fr) * 2008-02-02 2009-08-06 Tropical Health Systems Llc Procédé d'épuration du sang et appareil pour le traitement du paludisme

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE64957T1 (de) * 1984-02-22 1991-07-15 Wellcome Found Klonieren von dna fuer protozoenantigene.
AU5603786A (en) * 1985-04-11 1986-10-16 Walter And Eliza Hall Institute Of Medical Research, The Highly repetitive antigens - sharp-arp-mesa-plasmodium falciparum
US5130416A (en) * 1986-08-13 1992-07-14 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA clone containing a genomic fragment of PfHRP-II gene from plasmodium falciparum
US4721617A (en) * 1986-08-14 1988-01-26 Regents Of The University Of Minnesota Vaccine against lyme disease

Also Published As

Publication number Publication date
ES2037795T3 (es) 1993-07-01
PT88915B (pt) 1993-01-29
DK610588A (da) 1989-05-04
FI885023A0 (fi) 1988-11-01
PT88915A (pt) 1988-12-01
DE3737238A1 (de) 1989-05-18
FI885023L (fi) 1989-05-04
US5393523A (en) 1995-02-28
KR890008318A (ko) 1989-07-10
EP0315085B1 (fr) 1992-12-30
EP0315085A2 (fr) 1989-05-10
EP0315085A3 (en) 1990-05-02
JPH01165398A (ja) 1989-06-29
FI97479B (fi) 1996-09-13
DE3877136D1 (de) 1993-02-11
ATE83928T1 (de) 1993-01-15
KR970009346B1 (en) 1997-06-10
DK610588D0 (da) 1988-11-02
AU2459088A (en) 1989-05-25
AU618030B2 (en) 1991-12-12
GR3007476T3 (fr) 1993-07-30

Similar Documents

Publication Publication Date Title
MX9101042A (es) Adn y arn recombinantes y productos derivados de los mismos
CA2031811A1 (fr) Antigenes du toxoplasma gondii, leur preparation et leur utilisation
DK163062C (da) Antigen, immunogen, proteinholdig vaccine imod coccidiose
FI97479C (fi) Menetelmä Plasmodium falciparum SGE2 -kannan HRPII-antigeenin ja tätä antigeeniä sisältävän malariarokotteen valmistamiseksi, HRPII-antigeeniä koodaava DNA- ja RNA-sekvenssi ja tätä DNA:ta sisältävä vektori ja bakteerisolu
NO177570B (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
IL97013A (en) Immunoreactive protein of an eimeria merozoite surface antigen, dna encodidng it, the production of the protein and its use as a vaccine
NO902251D0 (no) Fremstilling av gonorrheiske p1-proteiner og vaksiner.
ATE127478T1 (de) Onkogen kodierendes polypeptid, das wachstumsfaktoraktivität besitzt, verfahren zu seiner herstellung und verwendung.
NZ233328A (en) Polypeptides produced by hepatocytes infected with p. falciparum; nucleic acid probes
DK145988D0 (da) Genteknologisk fremstillet 140 kd-antigen af plasmodium falciparum og dettes anvendelse
ATE87977T1 (de) Herstellung menschlichen somatomedins c.
DE68909041D1 (de) Eimeria tenella-Vakzin.
DE3876227D1 (de) Malaria-spezifische dna-sequenzen, ihre expressionsprodukte und deren verwendung.
NO902491D0 (no) Proteiner, vaksiner og nukleinsyrer.
ATE87934T1 (de) Synthetische, immunologisch aktive peptide, welche zur zubereitung von vakzinen gegen malaria dienen.
IE893702L (en) Dna sequence encoding the coat protein gene of potato¹leafroll virus

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: CHIRON BEHRING GMBH & CO.

MM Patent lapsed
MM Patent lapsed

Owner name: CHIRON BEHRING GMBH & CO.